- Reviewed by Toni Golen, MD, Editor in Chief, Harvard Women's Health Watch; Editorial Advisory Board Member, Harvard Health Publishing; Contributor
Women who have used hormone therapy for menopausal symptoms may be more likely to develop gastroesophageal reflux disease, or GERD, a new analysis suggests.
The study, published online June 27, 2023, by the journal Menopause, analyzed data from five earlier studies involving more than one million women, none of whom had been diagnosed with GERD before the study's start. Researchers found that participants who were current or past users of hormone therapy for relieving menopausal symptoms were 29% more likely over all to develop GERD, which is characterized by heartburn, difficulty swallowing, and chest pain. Women who used estrogen alone had a 41% higher odds of GERD, while progesterone-only hormone therapy was linked to a 39% higher risk. Hormone therapy combining estrogen and progesterone was associated with only a 16% higher risk for GERD.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.Sign Me Up
Already a member? Login ».
About the Author
Maureen Salamon, Executive Editor, Harvard Women's Health Watch
About the Reviewer
Toni Golen, MD, Editor in Chief, Harvard Women's Health Watch; Editorial Advisory Board Member, Harvard Health Publishing; Contributor
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.